Gene Logic last week appointed Mark Crane as vice president of marketing and business development for the company's preclinical division. Crane previously held marketing positions at Quest Pharmaceutical Services, MDS Pharma Services, Avantec, and PerkinElmer. In his new position with Gene Logic, Crane will be responsible for sales and marketing of preclinical services to pharmaceutical and biotechnology companies, as well as government organizations.
Charles River Laboratories has appointed Nicholas Ventresca as corporate senior vice president of information technology and chief information officer. Prior to joining Charles River Labs, Ventresca was vice president in business technology for Pfizer's corporate headquarters in New York and R&D headquarters in New London, Conn. He also served as CIO of Warner-Lambert's Schick & Wilkinson Sword group and CTO of Pepsi-Cola.
Frantisek Svec has joined the scientific advisory board of Protein Discovery, the company announced last week.
Svec is known for his contributions to the development of the monolithic chromatography column. He is presently working at the University of California Berkeley and the Lawrence Berkeley National Laboratory, where he continues to investigate the synthesis of new separations media for use in both conventional and microscale chromatography systems.
Svec received a PhD in polymer chemistry and a BS in chemistry from the Institute of Chemical Technology in Prague.
GE Healthcare this week launched two GenomiPhi products, the Illustra GenomiPhi HY and Illustra GenomiPhi V2 DNA-amplification kits, both of which are designed to prepare "large quantities" of genomic DNA from "minimal" starting materials, the company said in a statement. The GenomiPhi HY kit is a midi-scale DNA prep kit for as much as 50 µg in a 4-hour reaction, while the GenomiPhi V2 is intended for small-scale DNA preps, providing smaller amounts of DNA in approximately 90 minutes, GE said.